- Home
- ERIE vs DGX Comparison
ERIE vs DGX Comparison
Compare ERIE & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERIE
- DGX
- Stock Information
- Founded
- ERIE 1925
- DGX 1967
- Country
- ERIE United States
- DGX United States
- Employees
- ERIE N/A
- DGX N/A
- Industry
- ERIE Specialty Insurers
- DGX Medical Specialities
- Sector
- ERIE Finance
- DGX Health Care
- Exchange
- ERIE Nasdaq
- DGX Nasdaq
- Market Cap
- ERIE 19.2B
- DGX 20.5B
- IPO Year
- ERIE 1995
- DGX 1996
- Fundamental
- Price
- ERIE $319.78
- DGX $185.56
- Analyst Decision
- ERIE
- DGX Buy
- Analyst Count
- ERIE 0
- DGX 15
- Target Price
- ERIE N/A
- DGX $186.40
- AVG Volume (30 Days)
- ERIE 126.9K
- DGX 840.1K
- Earning Date
- ERIE 10-30-2025
- DGX 10-21-2025
- Dividend Yield
- ERIE 1.69%
- DGX 1.75%
- EPS Growth
- ERIE 17.80
- DGX 12.66
- EPS
- ERIE 11.95
- DGX 8.35
- Revenue
- ERIE $3,973,472,000.00
- DGX $10,522,000,000.00
- Revenue This Year
- ERIE $10.96
- DGX $11.13
- Revenue Next Year
- ERIE $8.12
- DGX $3.41
- P/E Ratio
- ERIE $26.97
- DGX $21.91
- Revenue Growth
- ERIE 12.00
- DGX 12.58
- 52 Week Low
- ERIE $306.80
- DGX $146.91
- 52 Week High
- ERIE $539.10
- DGX $191.49
- Technical
- Relative Strength Index (RSI)
- ERIE 44.87
- DGX 56.55
- Support Level
- ERIE $313.73
- DGX $178.54
- Resistance Level
- ERIE $329.75
- DGX $184.48
- Average True Range (ATR)
- ERIE 6.73
- DGX 3.45
- MACD
- ERIE 2.01
- DGX -0.17
- Stochastic Oscillator
- ERIE 55.86
- DGX 57.94
About ERIE Erie Indemnity Company
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.